116 related articles for article (PubMed ID: 35266103)
1. Results from Patient Interviews on Fatigue in Progressive Multiple Sclerosis and Evaluation of Fatigue Patient-Reported Outcome (PRO) Instruments.
Watson C; Scippa K; Barlev A; Kresa-Reahl K; Cole JC
Neurol Ther; 2022 Jun; 11(2):725-739. PubMed ID: 35266103
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of the FSIQ-RMS: A New Patient-Reported Questionnaire to Assess Symptoms and Impacts of Fatigue in Relapsing Multiple Sclerosis.
Hudgens S; Schüler R; Stokes J; Eremenco S; Hunsche E; Leist TP
Value Health; 2019 Apr; 22(4):453-466. PubMed ID: 30975397
[TBL] [Abstract][Full Text] [Related]
3. A novel disease specific scale to characterize the symptoms and impacts of fatigue in US adults with relapsing multiple sclerosis: A real-world study.
Azoulai M; Lévy-Heidmann T; Morisseau V; Wilczynski O; Le HH; Jamieson C; Charvet LE; Krupp LB; Lair L
Mult Scler Relat Disord; 2022 Mar; 59():103637. PubMed ID: 35168093
[TBL] [Abstract][Full Text] [Related]
4. Measuring Fatigue in Multiple Sclerosis: There may be Trouble Ahead.
Close J; Vandercappellen J; King M; Hobart J
Neurol Ther; 2023 Oct; 12(5):1649-1668. PubMed ID: 37353721
[TBL] [Abstract][Full Text] [Related]
5. Italian translation and validation of fatigue symptoms and impacts questionnaire in relapsing multiple sclerosis (FSIQ-RMS).
Ruotolo I; Sellitto G; Ianniello A; Petsas N; Castelli L; Galeoto G; Berardi A; Barletta V; Conte A; Pozzilli C
Neurol Sci; 2022 Aug; 43(8):4925-4932. PubMed ID: 35451663
[TBL] [Abstract][Full Text] [Related]
6. Meaningful Change Thresholds and Fatigue Severity Points on Patient-Reported Outcomes by the Fatigue Symptoms and Impacts Questionnaire in Patients With Relapsing Multiple Sclerosis.
Hudgens S; Katz EG; Davies E; Keenan A; Sidorenko T; Jamieson C
Value Health; 2024 May; 27(5):598-606. PubMed ID: 38401796
[TBL] [Abstract][Full Text] [Related]
7. Clinical variables influencing the perception of fatigue in people with multiple sclerosis: a cross-sectional study using FSIQ-RMS.
Sellitto G; Ruotolo I; Ianniello A; Felicetti F; D'Ambrosi G; Berardi A; Galeoto G; Conte A; Pozzilli C
BMC Neurol; 2024 Apr; 24(1):138. PubMed ID: 38664640
[TBL] [Abstract][Full Text] [Related]
8. Impact of multiple sclerosis phenotypes on burden of disease in Finland.
Purmonen T; Hakkarainen T; Tervomaa M; Ruutiainen J
J Med Econ; 2020 Feb; 23(2):156-165. PubMed ID: 31617776
[No Abstract] [Full Text] [Related]
9. A mixed methods approach towards understanding key disease characteristics associated with the progression from RRMS to SPMS: Physicians' and patients' views.
Ziemssen T; Tolley C; Bennett B; Kilgariff S; Jones E; Pike J; Tomic D; Piani-Meier D; Lahoz R
Mult Scler Relat Disord; 2020 Feb; 38():101861. PubMed ID: 31865132
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Impact of Fatigue in Progressive Multiple Sclerosis: A Mixed-Methods Analysis.
Penner IK; McDougall F; Brown TM; Slota C; Doward L; Julian L; Belachew S; Miller D
Mult Scler Relat Disord; 2020 Aug; 43():102207. PubMed ID: 32505026
[TBL] [Abstract][Full Text] [Related]
11. The relevance of fatigue to relapse rate in multiple sclerosis: Applying patient preference data to the OPTIMUM trial.
Fox RJ; Tervonen T; Phillips-Beyer A; Sidorenko T; Boyanova N; Brooks A; Hennessy B; Jamieson C; Levitan B
Mult Scler; 2023 Mar; 29(3):427-435. PubMed ID: 36550636
[TBL] [Abstract][Full Text] [Related]
12. Employment and absenteeism in working-age persons with multiple sclerosis.
Salter A; Thomas N; Tyry T; Cutter G; Marrie RA
J Med Econ; 2017 May; 20(5):493-502. PubMed ID: 28035846
[TBL] [Abstract][Full Text] [Related]
13. Understanding the Symptoms and Impacts Experienced by People with Relapsing-Remitting MS: A Qualitative Investigation Using Semi-Structured Interviews.
Barrett A; Olayinka-Amao O; Ziemssen T; Bharadia T; Henke C; Kamudoni P
Neurol Ther; 2024 Apr; 13(2):449-464. PubMed ID: 38345742
[TBL] [Abstract][Full Text] [Related]
14. Understanding the patient experience of chronic kidney disease stages 2-3b: a qualitative interview study with Kidney Disease Quality of Life (KDQOL-36) debrief.
Rydén A; Nolan S; Maher J; Meyers O; Kündig A; Bjursell M
BMC Nephrol; 2022 Jun; 23(1):201. PubMed ID: 35641914
[TBL] [Abstract][Full Text] [Related]
15. Differences in correlates of fatigue between relapsing and progressive forms of multiple sclerosis.
Herring TE; Alschuler KN; Knowles LM; Phillips KM; Morean WM; Turner AP; Ehde DM
Mult Scler Relat Disord; 2021 Sep; 54():103109. PubMed ID: 34237561
[TBL] [Abstract][Full Text] [Related]
16. Patients' Experiences in Transitioning to Secondary Progressive Multiple Sclerosis: Qualitative Interviews.
Lewis S; Wray SE; Evans E; Romano C; Bartolome L; Su W; Shah R; Russo PA
Neurol Ther; 2021 Dec; 10(2):887-904. PubMed ID: 34392498
[TBL] [Abstract][Full Text] [Related]
17. Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey.
Hadjimichael O; Vollmer T; Oleen-Burkey M;
Health Qual Life Outcomes; 2008 Nov; 6():100. PubMed ID: 19014588
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis by phenotype in Germany.
Engelhard J; Oleske DM; Schmitting S; Wells KE; Talapala S; Barbato LM
Mult Scler Relat Disord; 2022 Jan; 57():103326. PubMed ID: 35158442
[TBL] [Abstract][Full Text] [Related]
19. Usability of a Mobile App for Real-Time Assessment of Fatigue and Related Symptoms in Patients With Multiple Sclerosis: Observational Study.
Palotai M; Wallack M; Kujbus G; Dalnoki A; Guttmann C
JMIR Mhealth Uhealth; 2021 Apr; 9(4):e19564. PubMed ID: 33861208
[TBL] [Abstract][Full Text] [Related]
20. Standardizing fatigue measurement in multiple sclerosis: the validity, responsiveness and score interpretation of the PROMIS SF v1.0 - Fatigue (MS) 8a.
Kamudoni P; Johns J; Cook KF; Salem R; Salek S; Raab J; Middleton R; Henke C; Repovic P; Alschuler K; von Geldern G; Wundes A; Amtmann D
Mult Scler Relat Disord; 2021 Sep; 54():103117. PubMed ID: 34256350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
